Anesthetic Management of a Patient with Myasthenia Gravis During Hypothermic Cardiopulmonary Bypass

1998 ◽  
Vol 10 (3) ◽  
pp. 228-231 ◽  
Author(s):  
Hiroshi Ishimura ◽  
Takeyoshi Sata ◽  
Takahiro Matsumoto ◽  
Atsushi Takizuka ◽  
Akio Shigematsu
Keyword(s):  
Cardiopulmonary Bypass ◽  
Myasthenia Gravis ◽  
Anesthetic Management ◽  
Hypothermic Cardiopulmonary Bypass

scholarly journals Anesthetic Management of Total Aortic Arch Replacement in a Myasthenia Gravis Patient under Deep Hypothermic Circulatory Arrest

2019 ◽  
Vol 2019 ◽  
pp. 1-2 ◽  
Author(s):  
Mamiko Kondo ◽  
Yusuke Yoshikawa ◽  
Hirofumi Terada ◽  
Michiaki Yamakage
Keyword(s):  
Cardiopulmonary Bypass ◽  
Myasthenia Gravis ◽  
Circulatory Arrest ◽  
Anesthetic Management ◽  
Aortic Surgery ◽  
Deep Hypothermic Circulatory Arrest ◽  
Neuromuscular Blocking ◽  
Hypothermic Circulatory Arrest ◽  
Total Aortic Arch Replacement ◽  
Complete Reversal

The anesthetic management of myasthenia gravis patients undergoing cardiac or aortic surgery under cardiopulmonary bypass, especially with deep hypothermic circulatory arrest, is challenging. We describe a case of successful anesthetic management of a myasthenia gravis patient undergoing total arch replacement with deep hypothermic circulatory arrest under neuromuscular monitoring and complete reversal of the action of neuromuscular blocking drugs by sugammadex. The present case suggests that patients with well-controlled myasthenia gravis might be safely managed in cardiac or aortic surgery under cardiopulmonary bypass with deep hypothermic circulatory arrest.

The oxygen- and acid-base status during hypothermic cardiopulmonary bypass

1988 ◽  
Vol 48 ◽  
pp. 63-71 ◽  
Author(s):  
Ivar Gøthgen ◽  
Ole Siggaard-Andersen ◽  
Jens Rasmussen ◽  
Peter Wimberley ◽  
Niels Fogh. Andersen
Keyword(s):  
Cardiopulmonary Bypass ◽  
Acid Base ◽  
Hypothermic Cardiopulmonary Bypass ◽  
Acid Base Status

scholarly journals Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Kota Saito ◽  
Sho Ohno ◽  
Makishi Maeda ◽  
Naoyuki Hirata ◽  
Michiaki Yamakage
Keyword(s):  
Cardiac Surgery ◽  
Cardiopulmonary Bypass ◽  
Oxygen Saturation ◽  
Anesthetic Management ◽  
Perioperative Period ◽  
Maze Procedure ◽  
Intraoperative Awareness ◽  
Case Presentation ◽  
Venous Oxygen Saturation ◽  
Index Value

Abstract Background Remimazolam has less cardiovascular depressant effects than propofol in non-cardiac surgical patients. However, the efficacy and safety of remimazolam in cardiac surgery with cardiopulmonary bypass (CPB) have not been reported. We present a case of successful anesthetic management using remimazolam in cardiac surgery with CPB. Case presentation A 76-year-old female was scheduled for mitral valve repair, tricuspid annuloplasty, maze procedure, and left atrial appendage closure. We used remimazolam in induction (6.0 mg/kg/h) and maintenance (0.6–1.0 mg/kg/h) of general anesthesia, and the bispectral index value was maintained in the range of 36 to 48 including the period of CPB. Hemodynamics, mixed venous oxygen saturation, and bilateral regional cerebral oxygen saturation were maintained within acceptable ranges. There was no intraoperative awareness/recall or serious complications associated with remimazolam throughout the perioperative period. Conclusions Remimazolam can be used the same as other existing anesthetics in cardiac surgery with CPB.

Sodium Nitroprusside Metabolism in Children During Hypothermic Cardiopulmonary Bypass

1996 ◽  
Vol 40 (6) ◽  
pp. 357
Author(s):  
H. J. PRZYBYLO ◽  
G. W. STEVENSON ◽  
PAUL SCHANBACHER ◽  
CARL BACKER ◽  
RICHARD M. DSIDA ◽  
...  
Keyword(s):  
Cardiopulmonary Bypass ◽  
Sodium Nitroprusside ◽  
Hypothermic Cardiopulmonary Bypass
Sign in / Sign up

Export Citation Format

Share Document